TSPO and Alzheimer disease: In addition to doubts about the sensitivity of current TSPO tracers to detect subtle alterations in the prodromal stages of AD, there are data relating higher binding of [18F]DPA714 to slower cognitive decline, suggesting a neuroprotective role of microglial activation perhaps in the early phase of the disease (Hamelin et al., 2016).